Saudi Basic Industries Corporation

Our Hold view is not a call for flat earnings. The base case assumes that adjusted EBITDA margin recovers from 15.3% in FY2025 to 15.6% in FY2026 and 18.2% by FY2030, while adjusted EPS rises from SAR 0.69 to SAR 1.23 and then SAR 2.94. The issue is the price already paid for that recovery. Our FCFF DCF produces SAR 52.90 per share against a SAR 52.20 reference price. The next twelve-month dividend lifts modeled total return to 7.1%, but central-case price appreciation is only 1.3%.

The market therefore does not need a full earnings disappointment to challenge the valuation. It only needs recovery to arrive later or require more capital than assumed. A 100 bp increase in WACC reduces our value by about 17%, while a 150 bp margin shortfall reduces it by about 16%. This asymmetry matters because 79.8% of enterprise value is derived from cash flows beyond FY2030. Near-term execution evidence has less time to compound than a change in long-duration assumptions.

The constructive part of the thesis is operational. SABIC enters the investment cycle with low balance-sheet leverage, a broad manufacturing footprint, and disclosed projects that can expand saleable output. The Fujian complex is the largest identifiable growth mechanism, but our forecast does not treat construction completion as revenue. We assign only a 0.5% project-ramp contribution in FY2026 and 3.5% in FY2027, with later growth tapering as the asset approaches a more normal operating state.

A Buy would require evidence that the earnings recovery is both faster and less capital intensive than our base case. The most credible route is a combination of better product price/mix, recurring transformation savings, timely Fujian commissioning and free-cash-flow coverage of the dividend. A Sell would become more likely if weak spreads persist while capex and working capital remain elevated, because that combination would erode both earnings and the balance-sheet support for distributions.

A superficial recovery thesis would extrapolate lower rates, improving chemical prices and announced capacity into a conventional cyclical rebound. We take a narrower view. SABIC can report higher EBITDA without creating equivalent equity value if working capital, capex, non-controlling interests or divestiture leakage absorb the cash. Our variant question is therefore not simply whether EBITDA recovers; it is whether recurring cash returns improve after funding the asset base and protecting the balance sheet.

Three proof points matter. First, quarterly price/mix must improve without being offset by weaker operating rates. Second, project disclosures must progress from mechanical completion to commissioning, utilization and commercial qualification. Third, EBITDA must convert into cash after capex and working capital. The FY2026 base case deliberately keeps price/mix at negative 6.0%, assumes only 1.5% volume growth and allows a 0.5% project-ramp contribution. This is more conservative than treating the full project nameplate as immediately productive, but it still embeds a transition from a difficult FY2025 base.

The thesis can be wrong in two directions. We may be too cautious if constrained industry supply, stronger Asian demand and recurring cost savings raise spreads faster than assumed. We may be too optimistic if new global capacity prolongs weak utilization, or if the Fujian complex reaches mechanical completion but takes longer to achieve product qualification and steady-state output. Because both outcomes are plausible, the report uses explicit bear, base and bull paths instead of presenting a single forecast as certainty.

Our base case should be read as a set of falsifiable mechanisms. Price/mix, volume, project ramp, margin, capex and working capital are separately observable. When new evidence arrives, the relevant assumption should be revised and its effect traced consistently through Revenue, adjusted EPS, FCFF and valuation.

SABIC is economically a portfolio of conversion spreads rather than a single-product manufacturer. Feedstock and intermediate inputs are converted through large, capital-intensive assets into commodity chemicals, polymers, fertilizers and differentiated materials. Revenue therefore responds to both physical volume and realized product mix, while EBITDA depends on the spread between selling prices and feedstock, energy, logistics and conversion costs. High utilization can support unit economics, but it can also amplify a weak market if additional output is sold into oversupply.

The Q1 2026 segment mix illustrates why consolidated Revenue alone is insufficient. Petrochemicals generated about 83% of segment Revenue but only a 10.9% EBITDA margin. Agri-Nutrients represented roughly 10% of Revenue and produced a 50.7% EBITDA margin, while Specialties represented about 6% of Revenue at a 26.4% margin. Small changes in the high-margin businesses can therefore affect group EBITDA disproportionately, although non-controlling ownership means not every unit of consolidated profit accrues to SABIC shareholders.

Saudi Aramco's 70% ownership is strategically important but should not be translated into assumed private economics. Parentage may support feedstock coordination, capital access and strategic alignment, yet public disclosures do not reveal every transfer-pricing term or contractual protection. Our model uses disclosed group financials and subtracts non-controlling interests from consolidated enterprise value. It does not assign an unverified parent-company premium.

The reporting perimeter is also moving. Announced European Petrochemicals and regional Engineering Thermoplastics divestitures are treated as discontinued or transaction-dependent rather than recurring operations. This distinction protects the operating forecast from one-off disposal accounting, but it creates a separate equity bridge for proceeds, taxes, stranded costs and retained liabilities. Until closing terms are fully disclosed, the report does not use expected proceeds to manufacture upside.

Petrochemicals remains the dominant valuation driver because of its scale, even though current margins are below those of Agri-Nutrients and Specialties. Our FY2026 allocation assumes Petrochemicals grows one percentage point below the company rate, reflecting weak price/mix and the time required for new capacity to contribute. From FY2027 the segment receives a modest positive spread as Fujian ramps, but we do not assume that nameplate capacity translates directly into sales. Product qualification, operating rates, regional demand and realized spreads remain separate constraints.

Agri-Nutrients is the portfolio's principal earnings stabilizer at the Q1 2026 cut. The disclosed segment margin is materially above the group average, so nitrogen prices, gas economics and plant availability can influence consolidated EBITDA more than the segment's Revenue share suggests. The potential urea expansion from approximately 4.8 million tonnes to 7.4 million tonnes is not treated as committed base-case production. Feedstock allocation has been disclosed, but final investment, construction and commercial timing remain necessary gates.

Specialties offers differentiated applications and higher margins than commodity Petrochemicals, but the business is also affected by perimeter change. The Fujian Engineering Thermoplastics compounding plant is scheduled for mechanical completion by the end of Q3 2027, while regional ETP divestitures affect historical comparability. We therefore model Specialties as a bounded mix benefit rather than a source of unquantified premium growth.

The project ledger separates four states: construction, commissioning, ramp-up and steady state. The 1.8 million tonne Fujian ethylene complex is the largest disclosed capacity item and was reported as 98% complete, but our base forecast assigns only a small FY2026 contribution. The Petrokemya MTBE plant has started up and can support current output; the Ibn Zahr recovery system is already commissioned. Later projects, including the ethylene oxide catalyst plant, remain capex and execution items until operating evidence becomes available.

This discipline prevents a common sell-side error: adding announced capacity to Revenue while leaving capex, working capital, utilization and price pressure unchanged. In our model, capacity creates value only when saleable volume earns a return above the cost of capital after the cash required to bring it onstream.

Chemical earnings are governed by an interaction between demand, industry capacity and the marginal producer's cost. When demand grows faster than effective supply, operating rates rise and producers gain pricing power. When new capacity arrives into weak demand, producers compete on price to keep plants loaded, compressing spreads even if reported volumes remain resilient. This is why a volume increase is not automatically bullish for SABIC; the quality of volume depends on realized price/mix and the contribution margin earned on incremental tonnes.

The publicly available market series in this report are directional indicators, not estimates of SABIC's realized prices. US plastics and chemical producer-price indexes, energy benchmarks and fertilizer indexes help identify broad cycle direction, but they do not reproduce Middle East contract terms, product grades, freight or regional discounts. We use them to challenge management commentary and forecast direction, never as a direct replacement for company price/mix disclosure.

Our FY2026 base case assumes the cycle remains difficult. Revenue falls 4.0%, with positive volume and project ramp more than offset by negative price/mix. A genuine turn would require at least two forms of evidence: improving external price indicators and a company-reported price/mix bridge that is no longer deteriorating. Margin confirmation is equally important because a price increase can be consumed by feedstock, energy, freight or under-absorption.

The bull case assumes faster stabilization and higher operating leverage, while the bear case assumes weak price/mix persists and project contributions arrive more slowly. We do not assign a probability-weighted target because the historical dataset is too small to estimate regime probabilities reliably. The scenario range is instead used to show how much of the valuation depends on a cyclical recovery that has not yet been fully observed.

SABIC's Saudi production base can benefit from gas-based feedstock and integration, but a consolidated margin forecast cannot assume that every asset shares the same cost curve. Overseas crackers, specialty operations, joint ventures and product chains may be exposed to different feedstocks, utilities, freight and transfer-pricing arrangements. The public record does not provide a complete plant-by-plant cash-cost database, so we model cost advantage through observed segment margins and explicit margin scenarios rather than a fabricated global ranking.

Feedstock affects earnings through more than the purchase price of hydrocarbons. Yield, energy intensity, co-product credits, operating rate and logistics determine the cash conversion spread. A producer can have advantaged feedstock but still report weak EBITDA if product prices fall faster than input costs or if utilization is too low to absorb fixed conversion expense. Conversely, a tightening product market can expand margins before feedstock prices change materially.

Our base case moves adjusted EBITDA margin from 15.3% in FY2025 to 15.6% in FY2026, then gradually to 18.2% by FY2030. The progression reflects a mix of price normalization, project ramp and recurring transformation savings; it is not attributed entirely to feedstock. A 150 bp shortfall across the explicit forecast reduces DCF value by roughly 16%, making segment margin the most important quarterly validation metric after price/mix.

The mitigation case is therefore conditional. Domestic integration and transformation initiatives can cushion pressure, but they do not immunize the group from global oversupply or less advantaged overseas assets. We would raise normalized margins only after savings recur in segment results or operating disclosures show a durable improvement in conversion economics.

Q1 2026 Revenue by customer location is geographically broad: Rest of Asia contributed 25.1%, China 18.9%, Saudi Arabia 16.1%, the Americas 13.3%, Europe 9.2%, Africa 8.5% and Other markets 8.9%. This reduces dependence on a single country, but it should not be mistaken for economic independence. Many end markets share exposure to global manufacturing, construction, packaging, automotive, electronics and agricultural cycles.

Asia is the most important demand region in the disclosed mix, and China is also central to the Fujian growth plan. This creates both strategic proximity and execution concentration. Local production can improve market access and logistics, yet the value of new output still depends on Chinese demand, regional capacity additions and product spreads. A weak regional balance can offset the advantages of being closer to customers.

Currency exposure is similarly layered. The reporting currency is the Saudi riyal, but sales, feedstock, freight and overseas costs can reference different currencies or dollar-linked prices. Public geographic Revenue does not provide a complete transactional FX map. We therefore retain FX and freight in the scenario range instead of presenting a false hedge ratio.

For monitoring purposes, customer-location Revenue is more useful than legal-entity domicile because it indicates where demand is realized. It still cannot answer customer concentration, contract duration or product-level profitability. Those remain explicit data gaps rather than silently diversified assumptions.

FY2025 continuing Revenue was SAR 116.53bn, only about 1% below the restated FY2024 level, but adjusted EBITDA declined from SAR 20.98bn to SAR 17.88bn and EBIT fell from SAR 9.43bn to SAR 4.37bn. The divergence shows that the principal problem was not simply lost volume. Price/mix, spread compression, cost absorption and depreciation reduced the earnings generated from a broadly similar Revenue base.

Adjusted net income from continuing operations fell from SAR 5.88bn to SAR 2.07bn. Reported net income attributable to the parent was a SAR 25.78bn loss, dominated by discontinued operations and exceptional accounting rather than recurring earning power. For that reason, the forward model uses adjusted EPS for continuing operations and does not forecast reported EPS until disposal charges, retained liabilities and other special items can be bounded.

Cash generation was stronger than reported earnings in FY2025. Pro forma continuing operating cash flow was SAR 16.54bn and free cash flow was SAR 9.21bn, against reported capex of SAR 8.77bn. That evidence supports the view that the balance sheet can absorb a difficult operating year, but it does not establish a permanently covered dividend. FY2025 dividends per share were SAR 3.00 and the company page identifies payout above 100%.

Q1 2026 reinforces the need to separate earnings from cash. Revenue was SAR 26.15bn, adjusted EBITDA SAR 4.15bn and adjusted net income attributable to the parent SAR 0.82bn, while free cash flow was negative SAR 0.27bn and net debt was SAR 2.77bn. One quarter should not be annualized mechanically, but the cash result is an early warning that working capital and capex can delay conversion even when adjusted earnings remain positive.

Historical comparisons are perimeter-aware. FY2024 and FY2025 official continuing figures are retained together, while older third-party history remains a separate analytical series. We do not splice them into a smooth trend because doing so would create artificial growth and margin signals from accounting-perimeter changes.

The house forecast is a driver bridge rather than a time-series extrapolation. Annual Revenue is built from separately visible assumptions for volume, product price/mix, project ramp and reporting perimeter. This matters for a cyclical producer because identical Revenue growth can have very different quality. Volume gained through new low-margin capacity is not equivalent to price-led growth from tighter product markets.

FY2026 Revenue declines 4.0% to SAR 111.87bn. Positive 1.5% volume growth and a 0.5% project contribution are more than offset by negative 6.0% price/mix. FY2027 Revenue then rises 7.5% to SAR 120.26bn as price/mix turns positive and the Fujian ramp contributes 3.5%. Growth moderates to 6.0%, 4.5% and 4.0% in FY2028-FY2030 as the explicit project contribution fades.

Adjusted EBITDA is calculated from Revenue and a normalized margin path. The base margin improves by only 20 bps in FY2026, then by 150 bps versus the FY2025 reference in FY2027 and 290 bps by FY2030. The progression captures operating leverage and recurring savings, but it remains below an assumption of immediate full-cycle normalization. Segment Revenue is allocated from the company total using Q1 2026 mix and bounded growth spreads, then reconciled back to the consolidated forecast.

The EPS bridge begins with adjusted EBITDA, subtracts depreciation and amortization to derive EBIT, then incorporates finance and associate income, tax and non-controlling interests. Dividing adjusted net income attributable to the parent by 3.0bn shares produces adjusted EPS. Reported EPS is intentionally excluded because discontinued-operation and exceptional-item accounting cannot be forecast defensibly from current public information.

FCFF is derived from after-tax EBIT plus depreciation and amortization, less capex and working capital. The integrated statement model separately tracks cash, debt, receivables, inventory, payables, PP&E, non-controlling interests and parent equity. A disclosed other-assets bucket balances the selected statements; it is shown explicitly because public data does not support a precise forecast of every asset line.

Model selection remains conservative. The post-Q1 seasonal benchmark has the lowest observed Revenue WAPE at 10.1%, but only five eligible periods. The structural driver model is used as the primary analyst case because it can represent disclosed projects and perimeter changes, not because it has proven statistical superiority. Prior-year and consensus benchmarks remain visible calibration anchors.

The base case produces a staged recovery rather than a straight-line rebound. Revenue remains below the FY2025 level in FY2026, while adjusted EBITDA holds near SAR 17.40bn because margin improves slightly. Adjusted EPS rises to SAR 1.23 as the continuing-operation bridge normalizes, but the modeled SAR 3.00 dividend remains substantially above earnings per share. This is a liquidity-supported distribution, not an earnings-covered payout.

FY2027 is the first year in which the operating thesis becomes visible across all three statements. Revenue reaches SAR 120.26bn, adjusted EBITDA SAR 20.26bn and adjusted EPS SAR 1.87. FCFF rises to SAR 7.78bn before financing and distributions, while the selected cash-flow statement shows levered free cash flow of SAR 5.78bn after cash interest. The difference between these measures is preserved because enterprise valuation uses FCFF, whereas dividend capacity depends on cash available to equity and balance-sheet liquidity.

By FY2030, Revenue reaches SAR 138.54bn, adjusted EBITDA margin 18.2%, adjusted EPS SAR 2.94 and FCFF SAR 12.58bn. The path requires margin recovery, project execution and controlled reinvestment. It does not require a return to an exceptional commodity peak, but it does assume that current weakness is not permanent.

The balance sheet absorbs the dividend shortfall in the early years. Under the selected statement path, cash and short-term investments decline as distributions exceed levered free cash flow and no new debt is assumed. This is not a forecast of distress; starting liquidity is material. It is nevertheless a reason not to value the dividend independently of capex and working-capital requirements.

Forecast precision should be interpreted correctly. The displayed values are point estimates generated by a transparent set of assumptions, not statistical certainties. The scenario and risk sections show the range created by alternative operating paths, while the quarterly monitoring framework identifies which assumption should change when new evidence arrives.

FCFF DCF is the primary method because SABIC is capital intensive and the forecast explicitly models reinvestment. The base case discounts FY2026-FY2030 FCFF at an 8.5% WACC using mid-year convention and capitalizes FY2030 cash flow at 2.5% terminal growth. Consolidated enterprise value is adjusted for SAR 2.77bn net debt and SAR 25.13bn of non-controlling interests. The resulting equity value is SAR 52.90 per share.

The conclusion is deliberately less confident than the central number appears. Terminal value contributes 79.8% of enterprise value, meaning most of the DCF depends on cash flows outside the explicit forecast. A 100 bp increase in WACC reduces value to approximately SAR 43.78, while a 50 bp reduction in terminal growth lowers it to roughly SAR 48.86. These are model sensitivities, not probabilities, but they show that small long-term changes matter more than the 1.3% base-case price upside.

The dividend discount model produces SAR 47.94 and is used only as a cross-check. A dividend method can understate operating value during an investment phase or overstate equity support when distributions are funded from liquidity rather than recurring free cash flow. The reverse DCF indicates that the reference price embeds about 2.4% perpetual FCFF growth at the base WACC, close to our 2.5% assumption. The market and our central case are therefore expressing broadly similar long-run expectations.

Peer multiples are contextual rather than determinative. The reviewed companies differ by geography, feedstock, product mix, ownership and cycle position. Several peers are near trough earnings, making EV/EBITDA mechanically high and P/E not meaningful. Applying a median multiple without normalizing those differences would create false precision.

The bear value of SAR 15.67 and bull value of SAR 99.86 are intentionally wide because operating assumptions, WACC and terminal growth move together. We do not average them into a target price. The base value remains the reference, while the risk sensitivities show which individual assumptions create the largest downside.

Probability labels are analyst judgments based on current industry and company evidence; they are not frequencies estimated from a large historical sample. Impact labels are tied to deterministic shocks applied to the base DCF: below 5% is Low, 5% to 15% is Moderate and above 15% is High. Each sensitivity changes one defined mechanism while holding other assumptions constant, so it measures exposure rather than a complete alternative scenario.

Mitigation is assessed separately from probability. A company action can reduce the financial consequence of a risk without making the event less likely. The evidence-to-monitor field identifies the disclosure that would confirm, weaken or invalidate our current treatment.

Capital allocation is the point where the recovery thesis becomes an equity thesis. In FY2025 the company disclosed SAR 3.00 per share of dividends and a payout above 100%. Our FY2026 base case retains SAR 3.00, equivalent to SAR 9.0bn for the parent shares, while the integrated statement model produces about SAR 3.97bn of levered free cash flow before parent and non-controlling distributions. The shortfall is funded from liquidity in the model.

This treatment is not a prediction that the dividend must be cut. SABIC begins with substantial cash and low net debt, so a temporary gap can be absorbed. The risk is duration: repeated distributions above recurring cash generation would compete with project capex, reduce financial flexibility or eventually require more debt. Dividend safety therefore depends on the speed of margin recovery and the cash demands of the investment program, not only on accounting earnings.

Our capital hierarchy is maintenance and committed project spending first, balance-sheet resilience second, ordinary dividends third and discretionary growth or transaction deployment thereafter. This is an analytical ordering, not a statement of management policy. The model assumes no debt issuance in the selected path and makes declining liquidity visible rather than using an undisclosed financing plug.

Governance must also be read through the ownership structure. Saudi Aramco's 70% stake aligns SABIC with national industrial strategy and gives the parent decisive voting influence. Minority investors still require transparent related-party economics, disciplined project returns and clear treatment of non-controlling interests. We do not assign a governance premium or discount without transaction-specific evidence.

Sustainability initiatives can affect capex, operating cost, market access and long-run asset competitiveness. They are financially relevant when they change measurable energy intensity, carbon cost, product mix, customer qualification or regulatory exposure. The report does not convert broad sustainability statements into valuation uplift without a cash-flow bridge.

The strongest public evidence covers consolidated financial statements, current segment results, disclosed projects, geographic Revenue and selected operating metrics. Product-level realizations, plant utilization, customer contracts, private feedstock terms, transaction liabilities and historical point-in-time consensus are less transparent. Where evidence is unavailable, the report states the limitation rather than replacing it with an unsupported estimate.

Material analyst judgments include the pace of price/mix normalization, project-ramp timing, margin recovery, long-run capex, working capital, WACC and terminal growth. Each is disclosed through assumptions or sensitivities. Probability labels in the risk section are qualitative judgments; valuation impacts are deterministic calculations from the stated scenarios.

Forecast and valuation conclusions should be revised only when the underlying evidence or assumption changes. Any change to the target value, indicative rating or material risk classification should be accompanied by a consistent update to the affected financial statements, valuation bridge and disclosure.